Sponsor:
Bold Therapeutics, Inc.
Code:
NCT04421820
Conditions
Colorectal Cancer
Pancreatic Cancer
Gastric Cancers
Cholangiocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BOLD-100 in combination with FOLFOX Chemotherapy (Dose Expansion)
BOLD-100 in combination with FOLFOX Chemotherapy (Dose Escalation)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations